MedPath

EFFICACY OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING CAESAREAN SECTION: A RANDOMIZED DOUBLE BLIND CONTROLLED MULTICENTRE STUDY

Not Applicable
Completed
Conditions
REDUCING BLEEDING AT LOWER SEGMENT CESAREAN SECTION
REDUCING BLEEDING AT LOWER SEGMENT CESAREAN SECTIO
Registration Number
PACTR202208847435444
Lead Sponsor
ODUOLAOWOO BAMUS BABTUNDE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
142
Inclusion Criteria

Age?=?18 years
Patients admitted for primary or secondary caesarean section (Elective or Emergency)
Gestational age of 36 to 42 weeks of gestation
Singleton pregnancy
Informed consent form signed

Exclusion Criteria

History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial thrombosis (angina pectoris, myocardial infarction, stroke)
Any known cardiovascular, renal, or liver disorders
Autoimmune disease
Sickle cell disease
Severe hemorrhagic disease
Planned general anesthesia
Placenta previa
Abruptio placentae
Eclampsia, HELLP syndrome
Multiple pregnancy
In utero fetal death
Administration of low-molecular-weight heparin or antiplatelet agents during the week before delivery
Consent not obtained

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.